Selecting oral bioavailability enhancing formulations during drug discovery and development.

about

In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug.Designing, synthesis, and antimicrobial action of oxazoline and thiazoline derivatives of fatty acid esters.

P2860

Q33767372-C43E282E-0037-4755-90C5-261E493BB408 Q39228385-C3C42EBA-3C83-4D33-A778-E148F07E30B4

P2860

Selecting oral bioavailability enhancing formulations during drug discovery and development.

Item

http://www.wikidata.org/entity/Q38175527

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Selecting oral bioavailability ...... rug discovery and development.

@en

type

Item

label

Selecting oral bioavailability ...... rug discovery and development.

@en

prefLabel

Selecting oral bioavailability ...... rug discovery and development.

@en

P1476

Selecting oral bioavailability ...... drug discovery and development

@en

P2093

Sorin Emilian Leucuta

http://www.w3.org/2001/XMLSchema#string

P2860

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Chemogenomics: an emerging strategy for rapid target and drug discovery

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.

Drug-like properties and the causes of poor solubility and poor permeability.

In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.

Molecular properties that influence the oral bioavailability of drug candidates.

BDDCS applied to over 900 drugs.

The process of structure-based drug design.

P304

139-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.2014.877881

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sorin E Leucuta

P577

2014-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259586140

http://www.w3.org/2001/XMLSchema#string

P698

24387781

http://www.w3.org/2001/XMLSchema#string

Selecting oral bioavailability enhancing formulations during drug discovery and development.

about

P2860

P2860

Selecting oral bioavailability enhancing formulations during drug discovery and development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698